- Home
- Primary Care
- MedX Weekly: FDA Approves Sepiapterin for PKU, WHO Flags Hepatitis D as Carcinogenic & More

1w2 min read
Medical Article
Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Clears Sepiapterin for Phenylketonuria in All Age Groups The U.S. FDA has approved sepiapterin for the treatment of hyperphenylalaninemia in individuals with phenylketonuria (PKU), including both adults and children aged one month and
MedX Weekly: FDA Approves Sepiapterin for PKU, WHO Flags Hepatitis D as Carcinogenic & More
5469 Reached1 Comments
Similar Content

Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2465 Reached4 Comments6 Likes

Young Girl Presented with Irritability and Abnormal Behavior
2250 Reached10 Comments4 Likes

Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes

Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1865 Reached17 Comments9 Likes